Patents by Inventor Ross Edward Fellows

Ross Edward Fellows has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMAN CD33 ANTIBODIES AND GLUCOCORTICOID CONJUGATES
    Publication number: 20240173425
    Abstract: The present disclosure provides human CD33 antibodies and antibody glucocorticoid receptor agonist conjugates and methods of using the conjugates for the treatment of myeloid cell associated diseases.
    Type: Application
    Filed: June 21, 2023
    Publication date: May 30, 2024
    Applicant: Eli Lilly and Company
    Inventors: Forest Hoyt Andrews, Joshua Ryan Clayton, Ross Edward Fellows, Bo Ma, Ying Tang, Jacqueline Mary Wurst, Pia Pauliina Yachi, Chiao-Wen Yang
  • TRANSFERRIN RECEPTOR BINDING PROTEINS AND CONJUGATES
    Publication number: 20240059784
    Abstract: Provided herein are proteins comprising one monovalent human TfR binding domain (“human TfR binding proteins”), proteins comprising one monovalent mouse TfR binding domain (“mouse TfR binding proteins”), conjugates comprising such human or mouse TfR binding proteins, e.g., human TfR binding proteins-dsRNA conjugates, pharmaceutical compositions comprising human TfR binding proteins or conjugates, and methods of treating CNS diseases (e.g., neurodegenerative disease such as neurodegenerative synucleinopathy or tauopathy) using human TfR binding proteins or conjugates.
    Type: Application
    Filed: August 7, 2023
    Publication date: February 22, 2024
    Inventors: Riazul Alam, Alberto Alvarado, Forest Hoyt Andrews, Nicholas Alan Babb, Deepa Balasubramaniam, Guillermo S. Cortez, Johnny Eugene Croy, David Albert Driver, Ross Edward Fellows, Daniel Girard, Lacie Chauvigne-Hines, Feng Liu, Hiroaki Tani, Isabel C. Gonzalez Valcarcel, Scott Alan Lawrence, Nalini Hosahalli Kulkarni, Jeremy S York
  • TREM2 ANTIBODIES AND USES THEREOF
    Publication number: 20220281975
    Abstract: The present invention relates to TREM2 antibodies, and uses thereof, for treating diseases such as neurodegenerative diseases.
    Type: Application
    Filed: May 5, 2022
    Publication date: September 8, 2022
    Inventors: Forest Hoyt Andrews, Ross Edward Fellows, Ying Tang, Yaming Wang